Medplus Health Services Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,037 Cr +21.3% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
MH

Medplus Health Services Ltd

Q2 FY26

Medplus Health Services Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹1,679Cr
+6.5% YoY
+8.8% QoQ
Net profit
₹56Cr
+43.6% YoY
+33.3% QoQ
Margin
9%
+1 pp YoY
+1 pp QoQ
Price₹690
Market cap₹8.3K Cr
P/E39.4

The short version

MedPlus expects gradual growth in same-store sales growth (SSSG), targeting high-single digit growth (9-10%) within the next 2 years. MedPlus expects same-store sales growth (SSSG) to gradually improve to high-single digits (9%-10%) within the next 2 years.

From Medplus Health Services Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • MedPlus expects gradual growth in same-store sales growth (SSSG), targeting high-single digit growth (9-10%) within the next 2 years.
  • The company aims to continue adding 600 to 1,000 stores annually, including a mix of owned and franchisee stores.
  • Private label non-pharma category is growing steadily due to improved store layouts and increased impulsive buying.
  • Revenue growth is supported by deepening presence in southern and eastern India, with initial expansion into states like Chhattisgarh and Madhya Pradesh.
  • Diagnostics segment is currently a small part (<2%) and will expand only after crossing subscription thresholds.

2 more points from Medplus Health Services Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Diagnostics segment: No immediate expansion planned until subscription numbers cross 250,000.
  • Current diagnostic capex: INR 120+ crores spent to set up 12 diagnostic centers, including 4 large centers.
  • Future diagnostics expansion: On hold until better subscription numbers are achieved.
  • Store network expansion: Planning to add 600 to 1,000 stores annually (including franchisees).
  • Franchisee model: Still in pilot phase; future growth dependent on franchisee adoption.
  • Supply chain: New warehouses added and functional to improve fill rates.

2 more points from Medplus Health Services Ltd's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Medplus Health Services Ltd said on order book & pipeline — free account, 30 seconds.

Medplus Health Services Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Medplus Health Services Ltd Q2 FY26 results — key figures

Medplus Health Services Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue1,6791,576+6.5%1,543+8.8%
Operating profit (EBITDA)149124+20.2%131+13.7%
Operating margin9%8%+1 pp8%+1 pp
Profit before tax6948+43.8%53+30.2%
Net profit (PAT)5639+43.6%42+33.3%
EPS (₹)4.633.24+42.9%3.54+30.8%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.0K Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Retailing this season

  • Entero Healthcar (Q2 FY26)

    Growth driven by three factors: organic growth (13.4% in Q2), full-year impact of past acquisitions, and new acquisitions closing primarily in H2. Key concall…

  • Matrimony.com (Q2 FY26)

    The company is investing a few crores each quarter experimenting with new initiatives, including AI-based astrology services and adjacent businesses like…

  • Intrasoft Technologies (Q2 FY26)

    Revenue from Operations for the quarter ended September 25, 2025: ₹13,251.45 lakhs . Key investor presentation takeaways from Intrasoft Technologies's Q2 FY26 i

  • RattanIndia Ent (Q2 FY26)

    2,072 crore, up 18% from Rs. Key investor presentation takeaways from RattanIndia Enterprises Ltd's Q2 FY26 investor presentation — and how it ranks against sec

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Medplus Health Services Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Medplus Health Services Ltd Q2 FY26 results?

MedPlus expects gradual growth in same-store sales growth (SSSG), targeting high-single digit growth (9-10%) within the next 2 years. MedPlus expects same-store sales growth (SSSG) to gradually improve to high-single digits (9%-10%) within the next 2 years.

What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medplus Health Services Ltd planning capital expenditure?

Diagnostics segment: No immediate expansion planned until subscription numbers cross 250,000.

Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.